SensDx

We are participants of the Finał XIII edycji konkursu "Innowator Mazowsza" competition.
On November 3, 2021, the final meeting will be held, during which financial awards and prizes from the Partners of the competition will be awarded.
We invite you to an online broadcast of this event, which will be available on the Innowacyjne Mazowsze profile at: https://fb.me/e/2zU0LMzIe
Be with us on November 3 at 10:00
Keep your fingers crossed!

We are pleased to announce that from today it will possible to use Flu SensDx at home! Our product has just received a medical device certificate for self-testing from PCBC. This means that Flu SensDx safety, ease of use and reliability of the results were confirmed by a notified entity with the no. 1434 given by the European Commission!

Flu SensDx detects influenza viruses even at a very early stage of infection. It is characterized by high sensitivity, comparable to the reference RT-PCR method. Moreover, the test is simple to use - the application guides the user step by step, which means that anyone can perform it. The test result is obtained within 5-7 minutes.

The whole project was handled by Dr Sabina Żołędowska, our Quality and Certification Specialist and her Compliance and Quality team. Dr Sabina Żołędowska was responsible for the management of the whole certification process. It is also worth mentioning that Dr Sabina Żołędowska is also accountable for ISO13485 certification for SensDx - the standard confirmed with no remarks since 2019 by TUV Rheinland. Thanks to her and her team, it will be possible to use Flu SensDx at your home. What a great success! Congratulations to all people involved.

We invite you to familiarize yourself with our offer today on the website:
https://www.sensdx.eu/

Did you know that Flu SensDx is one of the most innovative products of Mazovia? SensDx S. A. was a laureate in the 3rd edition of the Startuj z Mazowsza competition in the Start category for the Flu Sensor product, which enables a quick and precise test for the presence of the influenza virus, even at a very early stage. It is a valuable source of medical information that gives a chance for the effective implementation of therapy with neuraminidase inhibitors.
You can read more at https://ybp.org.pl/blog/2021/10/26/czy-wiesz-ze-dzieki-innowacyjnym-startupom-z-programu-startuj-z-mazowsza-mozesz-zmienic-swoj-dzien-a-nawet-zycie-na-lepsze/

During the last year, society has learned a lot about diagnostic solutions and the importance of accurate diagnostic procedures. However, SensDx products are a new type of diagnostic solution. Stay tuned for more!